Sign in

NCT05054699CompletedPhase 2/3

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

Electroconvulsive Therapy Versus Magnetic Seizure Therapy: Clinical and Cognitive Outcomes

Source: ClinicalTrials.gov · Last updated 29 Sept 2026

Brief summary (registry, in English)

This study aims to compare the efficacy and safety profile of Magnetic Seizure Therapy and Electroconvulsive therapy.

Status (registry)
Completed
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
100 (actual)
First submitted
5 Sept 2021
Start date
31 May 2021
Primary completion date
30 Jun 2026
Lead sponsor
University of Sao Paulo
NCT number
NCT05054699

What you commit to

  • Study type: Interventional · Phase 2/3
  • Participants enrolled: 100
  • From 31 May 2021 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other psychiatric conditions such as Schizophrenia, Schizoaffective Disorder, Substance Abuse, Borderline Personality Disorder, PTSD, or Intellectual Deficiency
  • Depressive symptoms due to a clinical condition
  • Any clinical or neurological conditions without proper management

Other

  • Pregnancy
  • ECT or any other neuromodulation treatment on the last six months
  • Inability to consent

Who the study is looking for

  • Major Depressive Disorder or Bipolar Depression in accordance to the Diagnostic and Statistical Manual (DSM) criteria
  • Score equal to or great than 17 points on the Hamilton Depression Rating Scale
  • Treatment-resistant depression, defined as insufficient relief of symptoms after two different first line treatments using therapeutic doses and for four to six weeks
  • Adequate health and clinical conditions, as assessed by an anaesthesiologist and a psychiatrist

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of Psychiatry, HC-FMUSP
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.